Global effects of the DEAD‐box RNA helicase DeaD (CsdA) on gene expression over a broad range of temperatures CA Vakulskas, A Pannuri, D Cortés‐Selva, TR Zere, BM Ahmer, ... Molecular microbiology 92 (5), 945-958, 2014 | 69 | 2014 |
Innate and innate-like cells: the future of chimeric antigen receptor (CAR) cell therapy D Cortés-Selva, B Dasgupta, S Singh, IS Grewal Trends in pharmacological sciences 42 (1), 45-59, 2021 | 34 | 2021 |
Schistosoma mansoni Infection-Induced Transcriptional Changes in Hepatic Macrophage Metabolism Correlate With an Athero-Protective Phenotype D Cortes-Selva, AF Elvington, A Ready, B Rajwa, EJ Pearce, ... Frontiers in immunology 9, 2580, 2018 | 26 | 2018 |
Frecuencia de parásitos intestinales en expendedores de alimentos ubicados en los recintos de la UNAN-León DM Cortes Selva, MR Estrada Leyton, KY Areas Barrera, S Tellez Universitas (León). Revista Científica de la UNAN-León. Vicerrectoria de …, 2008 | 26 | 2008 |
Teclistamab, a B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM): correlative analyses from MajesTEC-1 D Cortes-Selva, T Casneuf, D Vishwamitra, S Stein, T Perova, S Skerget, ... Blood 140 (Supplement 1), 241-243, 2022 | 23 | 2022 |
Schistosome and intestinal helminth modulation of macrophage immunometabolism D Cortes‐Selva, K Fairfax Immunology 162 (2), 123-134, 2021 | 21 | 2021 |
Metabolic reprogramming of the myeloid lineage by Schistosoma mansoni infection persists independently of antigen exposure D Cortes-Selva, L Gibbs, JA Maschek, M Nascimento, T Van Ry, JE Cox, ... PLoS Pathogens 17 (1), e1009198, 2021 | 15 | 2021 |
IL‐4 promotes stromal cell expansion and is critical for development of a type‐2, but not a type 1 immune response D Cortes‐Selva, A Ready, L Gibbs, B Rajwa, KC Fairfax European journal of immunology 49 (3), 428-442, 2019 | 15 | 2019 |
NK cell phenotype is associated with response and resistance to daratumumab in relapsed/refractory multiple myeloma CPM Verkleij, KA Frerichs, MEC Broekmans, C Duetz, CA O’Neill, ... Hemasphere 7 (5), e881, 2023 | 14 | 2023 |
Maternal schistosomiasis impairs offspring Interleukin-4 production and B cell expansion D Cortés-Selva, L Gibbs, A Ready, HA Ekiz, R O’Connell, B Rajwa, ... PLoS pathogens 17 (2), e1009260, 2021 | 13 | 2021 |
P32 majestec-1: correlative analyses of teclistamab, a B-cell maturation antigen (BCMA) X CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM) N van de Donk, D Cortes-Selva, T Casneuf, D Vishwamitra, S Stein, ... HemaSphere 7 (S2), 28-29, 2023 | 3 | 2023 |
Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation KA Frerichs, CPM Verkleij, MV Mateos, TG Martin, C Rodriguez, A Nooka, ... Blood advances 8 (1), 194-206, 2024 | 2 | 2024 |
Mechanisms of Resistance and Relapse with Talquetamab in Patients with Relapsed/Refractory Multiple Myeloma from the Phase 1/2 MonumenTAL-1 Study D Vishwamitra, S Skerget, D Cortes, O Lau, C Davis, T Renaud, J Tolbert, ... Blood 142, 1933, 2023 | 1 | 2023 |
Immune Profiling of Multiple Myeloma Patients Treated with Daratumumab Monotherapy: Acquired and Primary Daratumumab-Resistance Is Associated with NK Cell Exhaustion CPM Verkleij, KA Frerichs, C Duetz, S Zweegman, PM Homan-Weert, ... Blood 138, 728, 2021 | 1 | 2021 |
Interleukin-4 (IL-4) maintains lymphocyte-stromal cell axis in peripheral lymph nodes DC Selva, AL Ready, KC Fairfax The Journal of Immunology 198 (1_Supplement), 63.19-63.19, 2017 | 1 | 2017 |
Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in MajesTEC-1 D Cortes-Selva, T Perova, S Skerget, D Vishwamitra, S Stein, ... Blood, 2024 | | 2024 |
Unraveling the Dynamics of T Cell-Dependent Bispecific Antibodies in Multiple Myeloma: Multi-Omic Insights from Primary Patient Cells DJ Wu, AS Chen, N Deangelis, D Cortes, J Morachis, B Titz, S Cases, ... Blood 142, 3659, 2023 | | 2023 |
Longitudinal Correlative Profiles of Responders, Nonresponders, and Those with Relapse on Treatment with Teclistamab in the Phase 1/2 MajesTEC-1 Study of Patients with Relapsed … D Vishwamitra, S Skerget, D Cortes, T Perova, O Lau, C Davis, Y Guo, ... Blood 142, 455, 2023 | | 2023 |
Maternal schistosomiasis impairs offspring IL-4 production and B cell expansion D Cortes-Selva, L Gibbs, A Ready, HA Ekiz, B Rajwa, KC Fairfax bioRxiv, 2020.08. 13.250274, 2020 | | 2020 |
Sex specific Schistosomiasis induced metabolic modulation of the myeloid lineage KC Fairfax, D Cortes-Selva, L Gibbs, B Rajwa, E Amiel, JE Cox The Journal of Immunology 204 (1_Supplement), 69.15-69.15, 2020 | | 2020 |